BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 23738999)

  • 1. Novel frontiers in epilepsy treatments: preventing epileptogenesis by targeting inflammation.
    D'Ambrosio R; Eastman CL; Fattore C; Perucca E
    Expert Rev Neurother; 2013 Jun; 13(6):615-25. PubMed ID: 23738999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-inflammatory drugs in epilepsy: does it impact epileptogenesis?
    Vezzani A
    Expert Opin Drug Saf; 2015 Apr; 14(4):583-92. PubMed ID: 25645535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammation and Epilepsy: Preclinical Findings and Potential Clinical Translation.
    Terrone G; Salamone A; Vezzani A
    Curr Pharm Des; 2017; 23(37):5569-5576. PubMed ID: 28950818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How to Find Candidate Drug-targets for Antiepileptogenic Therapy?
    Yu N; Lin XJ; Di Q
    Curr Neuropharmacol; 2020; 18(7):624-635. PubMed ID: 31989901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimized methods for epilepsy therapy development using an etiologically realistic model of focal epilepsy in the rat.
    Eastman CL; Fender JS; Temkin NR; D'Ambrosio R
    Exp Neurol; 2015 Feb; 264():150-62. PubMed ID: 25523813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy.
    Löscher W
    Epilepsy Res; 2002 Jun; 50(1-2):105-23. PubMed ID: 12151122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new frontier in epilepsy: novel antiepileptogenic drugs.
    Sasa M
    J Pharmacol Sci; 2006; 100(5):487-94. PubMed ID: 16799261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Inflammatory Small Molecules To Treat Seizures and Epilepsy: From Bench to Bedside.
    Dey A; Kang X; Qiu J; Du Y; Jiang J
    Trends Pharmacol Sci; 2016 Jun; 37(6):463-484. PubMed ID: 27062228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-mediated neuroprotection and antiepileptogenesis: animal data.
    Pitkänen A
    Neurology; 2002 Nov; 59(9 Suppl 5):S27-33. PubMed ID: 12428029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers for epileptogenesis and its treatment.
    Engel J; Pitkänen A
    Neuropharmacology; 2020 May; 167():107735. PubMed ID: 31377200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention or modification of epileptogenesis after brain insults: experimental approaches and translational research.
    Löscher W; Brandt C
    Pharmacol Rev; 2010 Dec; 62(4):668-700. PubMed ID: 21079040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventing epileptogenesis: A realistic goal?
    Terrone G; Pauletti A; Pascente R; Vezzani A
    Pharmacol Res; 2016 Aug; 110():96-100. PubMed ID: 27173399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiepileptogenic agents: how close are we?
    Temkin NR; Jarell AD; Anderson GD
    Drugs; 2001; 61(8):1045-55. PubMed ID: 11465868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory and immune mechanisms underlying epileptogenesis and epilepsy: From pathogenesis to treatment target.
    Mukhtar I
    Seizure; 2020 Nov; 82():65-79. PubMed ID: 33011590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation and reactive oxygen species as disease modifiers in epilepsy.
    Terrone G; Balosso S; Pauletti A; Ravizza T; Vezzani A
    Neuropharmacology; 2020 May; 167():107742. PubMed ID: 31421074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of epileptogenesis and preclinical approach to antiepileptogenic therapies.
    Łukawski K; Andres-Mach M; Czuczwar M; Łuszczki JJ; Kruszyński K; Czuczwar SJ
    Pharmacol Rep; 2018 Apr; 70(2):284-293. PubMed ID: 29477036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation in epileptogenesis after traumatic brain injury.
    Webster KM; Sun M; Crack P; O'Brien TJ; Shultz SR; Semple BD
    J Neuroinflammation; 2017 Jan; 14(1):10. PubMed ID: 28086980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of inflammation in epileptogenesis.
    Vezzani A; Friedman A; Dingledine RJ
    Neuropharmacology; 2013 Jun; 69():16-24. PubMed ID: 22521336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epileptogenesis, traumatic brain injury, and biomarkers.
    Engel J
    Neurobiol Dis; 2019 Mar; 123():3-7. PubMed ID: 29625256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New visions in the pharmacology of anticonvulsion.
    Löscher W
    Eur J Pharmacol; 1998 Jan; 342(1):1-13. PubMed ID: 9544786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.